ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.

Company profile
Ticker
THMO
Exchange
Website
CEO
Xiaochun Xu
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CESCA THERAPEUTICS INC., THERM0GENESIS CORP, THERMOGENESIS CORP
SEC CIK
Corporate docs
Subsidiaries
ThermoGenesis Corp. • Wholly-owned by ThermoGenesis Holdings, Inc. • CARTXpress Bio Inc. ...
IRS number
943018487
THMO stock data
News
HC Wainwright & Co. Maintains Buy on ThermoGenesis Holdings, Lowers Price Target to $1
12 Aug 22
ThermoGenesis Holdings Q2 EPS $(0.20) Up From $(0.38) YoY
11 Aug 22
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday
2 Aug 22
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session
1 Aug 22
12 Health Care Stocks Moving In Monday's Pre-Market Session
1 Aug 22
Press releases
ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update
11 Aug 22
ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update
9 Aug 22
Thinking about buying stock in Intel Corp, Thermogenesis, SIGA Technologies, Tonix Pharmaceuticals, or Sunrun?
29 Jul 22
Atlantic Therapeutics Announces the Appointment of Russell Medford MD, PhD as New US-Based Chairman
27 Jul 22
ThermoGenesis Holdings Announces Financial Results for the First Quarter Ended March 31, 2022 and Provides Corporate Update
19 May 22
Analyst ratings and price targets
Investment data
Securities sold
Number of investors
Calendar
11 Aug 22
16 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 4M | 4M | 4M | 4M | 4M | 4M |
Cash burn (monthly) | (no burn) | 388.92K | 480.67K | 423.42K | 314K | 539.75K |
Cash used (since last report) | n/a | 610.3K | 754.28K | 664.44K | 492.74K | 847K |
Cash remaining | n/a | 3.39M | 3.25M | 3.34M | 3.51M | 3.15M |
Runway (months of cash) | n/a | 8.7 | 6.8 | 7.9 | 11.2 | 5.8 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Jun 22 | Xu Xiaochun | Common Stock | Conversion | Acquire C | Yes | No | 0.2843 | 10,552,234 | 3M | 12,281,091 |
28 Jun 22 | Xu Xiaochun | Second Amended and Restated Convertible Note Common Stock | Conversion | Dispose C | Yes | No | 0.2843 | - | 3M | - |
27 May 21 | Cauble Jeffery | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.94 | 40,000 | 237.6K | 0 |
27 May 21 | Xu Xiaochun | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 5.94 | 240,000 | 1.43M | 0 |
Institutional ownership, Q1 2022
0.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 16 |
Opened positions | 2 |
Closed positions | 2 |
Increased positions | 1 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 187K |
Total shares | 277.65K |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 84.3K | $57K |
BLK Blackrock | 67.14K | $46K |
Geode Capital Management | 43.37K | $29K |
Susquehanna International | 26.94K | $18K |
STT State Street | 16.87K | $11K |
Two Sigma Securities | 16.08K | $11K |
NTRS Northern Trust | 10.79K | $7K |
MS Morgan Stanley | 7.77K | $5K |
Tower Research Capital | 3.45K | $2K |
RY Royal Bank Of Canada | 864 | $1K |
Financial report summary
?Competition
Baxter International • Vericel • BioCardia • Plus Therapeutics • Zimmer Biomet • Pluri • Mesoblast • Celyad OncologyContent analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
constructed, Europe, face, inception, obligation, opt, principle, Thailand
Removed:
August, ending, expiration, foot, longer, September, statement, terminated
Current reports
8-K
Driven by Sales of the AXP, Total Revenues for the Quarter Rose 38% Compared to Prior Year
11 Aug 22
8-K
Entry into a Material Definitive Agreement
28 Jul 22
8-K
Amendments to Articles of Incorporation or Bylaws
6 Jul 22
8-K
Other Events
5 Jul 22
8-K
Departure of Directors or Certain Officers
23 Jun 22
8-K
Departure of Directors or Certain Officers
16 Jun 22
8-K
Results of Operations and Financial Condition
19 May 22
8-K
ThermoGenesis Holdings Announces Year End 2021 Financial Results and Provides Corporate Update
28 Mar 22
8-K
Entry into a Material Definitive Agreement
28 Mar 22
8-K
Departure of Directors or Certain Officers
23 Mar 22
Registration and prospectus
S-1/A
IPO registration (amended)
28 Apr 22
S-1
IPO registration
11 Apr 22
424B5
Prospectus supplement for primary offering
3 Feb 22
424B5
Prospectus supplement for primary offering
20 May 20
424B5
Prospectus supplement for primary offering
26 Mar 20
424B5
Prospectus supplement for primary offering
6 Jan 20
S-8
Registration of securities for employees
12 Sep 19
S-3
Shelf registration
15 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
5 Nov 21
DEFA14A
Additional proxy soliciting materials
28 May 20
DEFA14A
Additional proxy soliciting materials
21 Apr 20
DEFA14A
Additional proxy soliciting materials
13 May 19
DEF 14A
Definitive proxy
30 Apr 19
PRER14A
Preliminary revised proxy
21 Apr 19
PRE 14A
Preliminary proxy
3 Apr 19
Other
EFFECT
Notice of effectiveness
6 Jan 20
CORRESP
Correspondence with SEC
30 Dec 19
CORRESP
Correspondence with SEC
25 Dec 19
UPLOAD
Letter from SEC
17 Dec 19
SD
Conflict minerals disclosure
11 Jul 19
EFFECT
Notice of effectiveness
31 May 19
CORRESP
Correspondence with SEC
27 May 19
UPLOAD
Letter from SEC
27 May 19
EFFECT
Notice of effectiveness
25 Sep 18
CORRESP
Correspondence with SEC
23 Sep 18
Ownership
SC 13D/A
ThermoGenesis / Boyalife Asset Holding II ownership change
5 Aug 22
SC 13D/A
ThermoGenesis / Boyalife Asset Holding II ownership change
12 Jul 22
4
ThermoGenesis / Xiaochun Xu ownership change
30 Jun 22
3
ThermoGenesis / VIVIAN H LIU ownership change
27 Jun 22
3
ThermoGenesis / Haihong Zhu ownership change
27 Jan 22
4
ThermoGenesis / Xiaochun Xu ownership change
1 Jun 21
4
ThermoGenesis / Jeffery Cauble ownership change
1 Jun 21
SC 13G/A
ThermoGenesis / RENAISSANCE TECHNOLOGIES ownership change
10 Feb 21
4
ThermoGenesis / Jeffery Cauble ownership change
8 Jun 20
4
ThermoGenesis / Xiaochun Xu ownership change
8 Jun 20
Transcripts
2022 Q2
Earnings call transcript
13 Aug 22
2022 Q1
Earnings call transcript
19 May 22
2021 Q4
Earnings call transcript
28 Mar 22
2021 Q3
Earnings call transcript
13 Nov 21
2021 Q2
Earnings call transcript
13 Aug 21
2021 Q1
Earnings call transcript
13 May 21
2020 Q4
Earnings call transcript
18 Mar 21
2020 Q3
Earnings call transcript
12 Nov 20
2020 Q2
Earnings call transcript
14 Aug 20
2020 Q1
Earnings call transcript
14 May 20
Reddit threads
Daily Discussion Thread - August 11th, 2022
11 Aug 22
Daily Discussion Thread - August 10th, 2022
10 Aug 22
Day-Trading 2.4K to 25,000. Day 3(+$52.81)
29 Jul 22
Finally getting the hang of this
9 Jul 22
Daily Plays July 06, 2022
6 Jul 22
What Are Your Moves Tomorrow - July 06, 2022
5 Jul 22
Daily Discussion Thread - May 19th, 2022
19 May 22
Daily Discussion Thread - May 18th, 2022
18 May 22
Daily Discussion Thread - May 12th, 2022
12 May 22
Daily Discussion Thread - May 11th, 2022
11 May 22